The Cooper Institute logo
Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium
May 15, 2024 12:17 ET | Cooper Aerobics
New research from The Cooper Institute® + partners shows exercising, even at very high levels, is unrelated to progression of coronary artery calcium (CAC)
Venture Partnership Logo.png
Venture Partnership: Leading Medical Recruitment Agency Secures Coveted Framework Award
May 15, 2024 09:00 ET | Venture Partnership
Uxbridge, England, May 15, 2024 (GLOBE NEWSWIRE) -- Venture Partnership, a leading recruitment agency focused on providing permanent and locum doctor staffing solutions to the primary, acute, and...
MnM_logo_TM_JPG.JPG
Oligonucleotide Synthesis Market is Expected to Reach $19.7 billion | MarketsandMarkets™
May 15, 2024 08:30 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, May 15, 2024 (GLOBE NEWSWIRE) -- Oligonucleotide Synthesis market in terms of revenue was estimated to be worth $8.8 billion in 2024 and is poised to reach $19.7 billion by 2029, growing at...
Neuronetics_logo-RGB purple.png
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
May 15, 2024 07:32 ET | Neuronetics
MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
lumos.png
Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
May 14, 2024 16:15 ET | Lumos Pharma, Inc.
Outcome from End-of-Phase 2 Meeting Supportive of a Placebo-Controlled Phase 3 Trial Updated 12 and 24-Month Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials Continue to Show Oral LUM-201...
Saladax Biomedical, Inc. 5-FU Fact Sheet
Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test
May 14, 2024 10:00 ET | Saladax Biomedical, Inc.
Bethlehem, PA, May 14, 2024 (GLOBE NEWSWIRE) -- Saladax Biomedical, Inc. (Saladax) is pleased to announce that Health Canada has approved Saladax’s 5-Fluorouracil (My5-FU) Assay for sale in Canada...
MnM_logo_TM_JPG.JPG
FEP Heat Shrink Medical Tubing Market worth $208 million by 2029 Globally, at a CAGR of 7.4%, says MarketsandMarkets™
May 14, 2024 04:30 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, May 14, 2024 (GLOBE NEWSWIRE) -- The Global FEP Heat Shrink Medical Tubing Market is projected to grow from USD 145 million in 2024, and it is projected to reach USD 208 million by 2029, at...
Pacific Health Care Organization, Inc. Reports its First Quarter 2024 Results
May 13, 2024 20:22 ET | Pacific Health Care Organization, Inc.
Irvine, May 13, 2024 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its...
Fractyl-Logo.png
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
May 13, 2024 16:00 ET | Fractyl Health, Inc.
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
King Faisal Specialist Hospital and Research Centre Welcomes New Deputy CEO Amid Strategic Transformations
King Faisal Specialist Hospital and Research Centre Welcomes New Deputy CEO Amid Strategic Transformations King Faisal Specialist Hospital and Research Centre Welcomes New Deputy CEO Amid Strategic Transformations